Source comparison
CJC-1295 no DAC vs Other Growth Hormone Secretagogues: Injection Discomfort Comparison
Understanding how CJC-1295 no DAC injection pain compares to other peptides in the same therapeutic category helps contextualize whether the discomfort is peptide-specific or administration-related. CJC-1295 no DAC 2–3× daily 6–7 Low solution pH + rapid absorp
This comparison does not assign a generated winner or score.
- Understanding how CJC-1295 no DAC injection pain compares to other peptides in the same therapeutic category helps contextualize whether the discomfort is peptide-specific or administration-related.
- CJC-1295 no DAC
- 2–3× daily
- 6–7
- Low solution pH + rapid absorption
- Higher discomfort due to frequency and concentration; dilution to 2.5mL reduces score to 3–4
- CJC-1295 with DAC
- 1–2× weekly
- 3–4
- Mild localized inflammation from DAC attachment
- DAC modification slows absorption, reducing acute sting but causing mild site tenderness for 12–24 hours
- Ipamorelin
- 2–3
- Minimal. Near-neutral pH, slow diffusion
- One of the most comfortable peptides; pH closer to 6.5 post-reconstitution
- GHRP-2
- 4–5
- Moderate pH differential, rapid onset
- Comparable to CJC-1295 no DAC but shorter duration; sting resolves within 60 seconds
- Hexarelin
- 5–6
- Low pH + histamine release
- Causes brief flushing and warmth in addition to injection site sting; consider Hexarelin for research comparing discomfort profiles
- MK-677 (oral)
- 1× daily
- 0
- No injection required
- Oral bioavailability eliminates injection discomfort entirely; MK 677 offers an alternative for researchers prioritizing comfort
- CJC-1295 no DAC sits at the higher end of the discomfort spectrum primarily because of administration frequency. The peptide itself is not uniquely painful, but injecting 2–3 times daily with suboptimal technique compounds tissue irritation rapidly. Switching to CJC-1295 with DAC reduces injection frequency to once or twice weekly, which many researchers find more manageable despite slightly longer post-injection site tenderness.